Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Behringwerke AG, a subsidiary of Sanofi, is a German company located in Marburg. The firm produces specialty chemicals and pharmaceutical products.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Fidia Farmaceutici SpA manufactures pharmaceutical products. The firm's platform technology level is the chemical modification, development, and manufacturing of state-of-the-art pharmaceuticals and medical devices based on hyaluronan covering therapeutic categories. The company was founded in 1946 and is headquartered in Abano Terme, Italy.

Part of Teva Pharmaceutical Industries Ltd., Pharmachemie BV (doing business as Teva Pharmachemie BV) is a company headquartered in Haarlem, the Netherlands, that produces pharmanceutical products.

Inco Alloys International operates as an integrated nickel alloy processing mill in Huntington. The company develops products of nickel, monel, inconel, incoloy, inco-weld, incoclad, and nilo families of nickel alloys.

Engelhard Corporation, Pension Arm is a corporate pension fund that has $400 million assets under management. The fund's alternative investment strategy focuses primarily on venture capital. Engelhard Corporation, Pension Arm will commit from $2 million to $10 million per partnership and has a net internal rate of return target of 25%. The fund allocates a maximum of 5% or about $20 million of its total assets to alternative investments. It was formed in 1994 and is based in Iselin, New Jersey.

Warner-Lambert Co. used to manufacture and market pharmaceuticals, consumer health care products & confectionery. Its pharmaceutical products were ethical pharmaceuticals, biological products and hard-gelatin capsules. Its consumer health products were a wide range of products like oral care mouthwash/dental rinses, toothpaste, effervescent denture cleaning tablets, upper respiratory cold & sinus preparations, antihistamines, allergy products and cough syrups/suppressants. The company was headquartered in Morris Plains, NJ.

Manufactures chemicals, pharmaceuticals and metals

Zhejiang Meixin Holdings Co., Ltd., established on 2021-12-20, Business scope includes general items:Holding Company Services;Corporate Headquarters Management;business management;Business Management Consulting;Information Consulting Service(Not including licensing information consulting services);Food Additive Sales;Feed Additive Sales;Chemical product sales(No licensed chemical products);Specialty Chemicals Sales(Free of Hazardous Chemicals);Sales of Class I Medical Devices;Sales of Class II Medical Devices;Chemical product production(No licensed chemical products);Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;New material technology research and development;Biochemical product technology research and development;Engineering and Technology Research and Experimental Development;marketing planning;Technology Import and Export;Import and export;Non-residential real estate leases;property management;Production of Class I Medical Devices(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:pharmaceutical production;Production of Class II Medical Devices;Health food production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Pharmaceuticals

Tanaka Kikinzoku Kogyo KK manufactures, sells, imports, and exports industrial metal products. Its products include platinum, gold, silver and others. The firm also does refining and recycling of precious metals. The company was founded in 1885 and is headquartered in Tokyo, Japan.

AnorMED, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic drugs for the treatment of hematology, human immunodeficiency virus (HIV), and oncology. Its lead drug product candidate include MOZOBIL, which is under phase III clinical trial is used for cancer patients undergoing stem cell transplantation; and AMD070, which is under phase Ib/IIa trial is used as a HIV entry inhibitor.

Toyama Chemical Co., Ltd. develops and supplies pharmaceutical products. It engages in information collection, clinical development of pharmaceuticals and distribution of healthcare products. The company was founded on November 15, 1936 and is headquartered in Tokyo, Japan.

Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA.

Lachema as produces and sells pharmaceuticals and chemicals. It focuses on the research, development and production of medical products used in the treatment of serious diseases - cancer, cardiovascular diseases or viral infections. The company exports its products to Western Europe and United States of America. Lachema was founded in March 27, 1991 and is headquartered in Brno, Czech Republic.

ICCAS was founded in 1956. ICCAS is a multi-disciplinary research institute dedicated to the basic research in broad fields of chemical sciences, and to the key developments of the innovative high technologies aiming to the imperative national needs and important strategic targets, as well as to the collaborative high-technology applications and transfers. ICCAS is one of China’s leading chemistry research institutions with high international reputation.